Form 4: Coherent Corp. Chief Innovation Officer Sells Shares Under 10b5-1 Plan

Coherent Corp.'s Chief Innovation Officer, Christopher Koeppen, sold a total of 5,164 shares of common stock in two transactions under a pre-arranged 10b5-1 trading plan.

Summary

• Christopher Koeppen, Chief Innovation Officer of Coherent Corp., executed two sales of common stock.
• The first sale occurred on November 22, 2024, where 2,248 shares were sold at a price of $105.0047 per share.
• The second sale took place on December 16, 2024, with 2,916 shares sold at $108.84 per share.
• These transactions were conducted under a pre-arranged Rule 10b5-1 trading plan adopted on June 15, 2023.
• Following these sales, Mr. Koeppen directly owns 55,338 shares of Coherent Corp. common stock.
• Mr. Koeppen also indirectly owns shares through his daughter and son, but the exact number of shares is not specified in this document.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged trading plan, with no indication of positive or negative sentiment.

Risks

• The sales by a high-ranking officer could be perceived negatively by some investors, although they were conducted under a pre-arranged trading plan.

Industry Context

This is a routine disclosure of insider trading activity, which is common for publicly traded companies. The use of a 10b5-1 plan indicates that the sales were pre-planned and not based on any non-public information.

Comparison to Industry Standards

• The use of a 10b5-1 trading plan is a common practice among executives at publicly traded companies to avoid accusations of insider trading.
• The reported transactions are typical for executives managing their personal portfolios and are not unusual in the context of corporate governance.

Stakeholder Impact

• The sales may have a minor impact on shareholder sentiment, but the pre-planned nature of the transactions should mitigate any significant concerns.

Key Dates

Keywords

Coherent Corp, insider trading, stock sale, Rule 10b5-1, Christopher Koeppen, Chief Innovation Officer, COHR